Carprodyl Quadri
Active substance
ATC code
Species
Dogs.
Indications
In the dog:
Reduction of inflammation and pain caused by musculo-skeletal disorders and degenerative joint disease.
As a follow-up to parenteral analgesia in the management of post-operative pain.
Dose to be administered and administration route
For oral administration.
4 mg carprofen per kg bodyweight per day.
An initial dose of 4 mg carprofen per kg bodyweight per day given as a single daily dose. The analgesic effect from each dose persists for at least 12 hours.
The daily dose may be reduced, subject to clinical response.
Duration of treatment will be dependant upon the response seen. Long term treatment should be under regular veterinary supervision.
To extend analgesic and anti-inflammatory cover post-operatively parenteral preoperative treatment with an injectable carprofen may be followed with carprofen tablets at 4 mg/kg/day for 5 days. Do not exceed the stated dose.
The breakability method is the following: Put the tablet on a plain surface, with its scored side facing the surface (convex face up).
With the tip of forefinger, exert a slight vertical pressure on the middle of the tablet to break it in its width into halves. In order to obtain quarters, then exert a slight pressure on the middle of one half with forefinger to break it in its length.
The tablet is divisible and can be used as follows:
Number of tablets per day | Dog weight (kg) | |
¼ | > 3 - ≥ 6 - ≥ 9 - ≥ 12.5 - ≥ 15.5 - ≥ 18.5 - ≥ 21.5 - ≥ 25 - ≥ 28 - ≥ 31 - ≥ 34 - ≥ 37 - ≥ 40 - ≥ 43 - | < 6 < 9 < 12.5 < 15.5 < 18.5 < 21.5 < 25 < 28 < 31 < 34 < 37 < 40 < 43 < 45 |
½ | ||
¾ | ||
1 | ||
1 ¼ | ||
1 ½ | ||
1 ¾ | ||
2 | ||
2 ¼ | ||
2 ½ | ||
2 ¾ | ||
3 | ||
3 ¼ | ||
3 ½ |
The tablets are flavoured, and are accepted by dogs, but they may be administered directly in the mouth of the dog or added to food if necessary.
Adverse reactions
Typical undesirable effects associated with NSAIDs, such as vomiting, soft faeces/diarrhea, faecal occult blood, loss of appetite and lethargy have been reported. These adverse reactions generally occur within the first treatment week and are in most cases transient and disappear following termination of the treatment but in very rare cases may be serious or fatal.
If adverse reactions occur, use of the product should be stopped and the advice of a veterinarian should be sought.
As with other NSAIDs there is a risk of rare renal or idiosyncratic hepatic adverse events.
PRICE | Only for registered vets. Create a free profile to access all features.. Login |
---|---|
Art. Nr. | 15052/5060 |
EAN | 3411112263981 |